iShares Morningstar Small-Cap Growth ETF ISCG
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +10.49%
- 1 year
- +11.20%
- Open
- 61.99
- Prev close
- 62.50
- Mkt cap
- 981.25M
- Vol
- 79.70K
- Avg vol
- 24.15K
- EPS
- 2.58
- P/E
- 23.71
- Div yield
- 0.00%
More statistics
- Low
- 60.61
- High
- 61.90
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 64.14
- 200-d avg
- 59.96
- 1y target
- 0.00
News
3 days ago zacks.com
Should iShares Morningstar Small-Cap Growth ETF (ISCG) Be on Your Investing Radar?
Designed to provide broad exposure to the Small Cap Growth segment of the US equity market, the iShares Morningstar Small-Cap Growth ETF (ISCG) is a passively managed exchange traded fund launched on…
3 days ago fool.com
Vanguard Russell 1000 Growth ETF vs. iShares Morningstar Small-Cap Growth ETF: Could Small-Cap Stocks Outshine Tech Giants?
Vanguard Russell 1000 Growth ETF offers exposure to established growth leaders, with the majority of its portfolio concentrated in technology. iShares Morningstar Small-Cap Growth ETF spreads its…
2 months ago benzinga.com
Roku Stock Edges Higher Friday: What's Driving the Post-Earnings Move?
Roku Inc. (NASDAQ: ROKU) shares are trading higher on Friday as investors digest second-quarter results and a deal-driven update cycle.
5 months ago benzinga.com
Billionaire Investor Quietly Loads Up On Construction Stocks As One Gets The Axe
Daniel Loeb's Third Point increased stakes in APi Group and MasTec while reducing exposure to Comfort Systems in Q4 FY25 portfolio reshuffle.
6 months ago benzinga.com
Neurocrine Buys Soleno To Tap High-Growth Rare Disease Market
Neurocrine (NBIX) to acquire Soleno Therapeutics (SLNO) for $2.9B to expand its rare disease portfolio. Get the deal details here.